PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Cash from Investing Activities for 7 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 58.71% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$10.4 million (down 142.71% YoY), while the FY2025 annual figure was -$9.4 million, down 112.2% from the prior year.
• Cash from Investing Activities slipped to -$2.9 million in Q1 2026 per PRCT's latest filing, from -$1.8 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$55000.0 in Q1 2022 and bottomed at -$8.7 million in Q4 2023.
• Historically, Cash from Investing Activities has averaged -$2.6 million across 5 years, with a median of -$1.8 million in 2025.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 9607.27% — and 2024, when it jumped 95.74%.
• PROCEPT BioRobotics' Cash from Investing Activities stood at -$866000.0 in 2022, then slumped by 906.35% to -$8.7 million in 2023, then surged by 86.53% to -$1.2 million in 2024, then tumbled by 57.58% to -$1.8 million in 2025, then tumbled by 57.51% to -$2.9 million in 2026.
• Business Quant data shows PRCT's Cash from Investing Activities at -$2.9 million in Q1 2026, -$1.8 million in Q4 2025, and -$2.9 million in Q3 2025.